These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3376643)

  • 1. [Circulating tissue antigens in multiple sclerosis and hepatocerebral dystrophy].
    Makarova VA; Geskin IuF; Shirokova TA; Zubzhitskiĭ IuM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):24-7. PubMed ID: 3376643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of blood-brain barrier permeability for complement-fixing antibodies in the pathogenesis of disseminated sclerosis].
    Leonovich AL; Ziuzenkov VV; Sizonenko TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(3):345-9. PubMed ID: 5027045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complement fixation reactions with extracts from demyelinating foci and with other lipid posessing antigens in multiple sclerosis. Critical studies including clincal control groups].
    Roemer GB; Mai K
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(4):370-90. PubMed ID: 4233550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Virus neutralizing and antibrain antibodies in multiple sclerosis and multiple encephalomyelitis].
    Zinchenko AP; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):541-8. PubMed ID: 4301248
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of disseminated sclerosis].
    Musatova IV; Khondkarian OA; Nevskaia OM; Gaĭdamakina AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(3):339-45. PubMed ID: 5027044
    [No Abstract]   [Full Text] [Related]  

  • 6. [The pathogenesis of multiple sclerosis. Basal membrane injury by persisting viral infection].
    Simon J
    Fortschr Med; 1989 Jan; 107(1):53. PubMed ID: 2920985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunologic differentiation of brain antigens in multiple sclerosis].
    Panov AG; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):161-70. PubMed ID: 636708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of a factor inhibiting migration of leukocytes to brain antigens, its concentration in serum and spontaneous leukocyte migration in multiple sclerosis].
    Loĭko TP; Ierusalimskiĭ AP; Lozovoĭ VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):187-90. PubMed ID: 3518311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis.
    Daar AS; Fabre JW
    Clin Exp Immunol; 1981 Jul; 45(1):37-47. PubMed ID: 7030539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on autoantibodies in multiple sclerosis].
    Szabó S; Lukács E; Lapohos E; Malatinszky EG; Wagner RC; Becuş T
    Stud Cercet Neurol; 1968; 13(1):19-27. PubMed ID: 5665111
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
    Dachsel R; Felber F; Liebert A
    Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical picture and differential diagnosis of the hyperkinetic form of multiple sclerosis and hepatocerebral dystrophy].
    Iarosh AA; Macheret EL; Iarosh AA; Prokopiv MM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1800-2. PubMed ID: 4090838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abnormal iron metabolism in the special type of hepatocerebral encephalopathy. I. Clinical and pathological findings of four cases of special type of hepatocerebral encephalopathy with hemochromatosis].
    Saito A
    Seishin Shinkeigaku Zasshi; 1984; 86(3):153-66. PubMed ID: 6484049
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune reactivity to brain and viral antigens in multiple sclerosis patients: detection by the leucocyte adherence inhibition assay.
    Mayer M; Opavský J; Bártová A
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():277-83. PubMed ID: 6085908
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tissue antigens. I. Tissue antigens in serum of patients with diseases involving injury of the liver and of other organs.
    Espinosa E
    Clin Exp Immunol; 1974 Feb; 16(2):153-62. PubMed ID: 4219874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence and properties of a serum hepatic antigen in various liver diseases.
    Espinosa E
    Ann Clin Lab Sci; 1985; 15(4):308-14. PubMed ID: 4037702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity in multiple sclerosis as determined by sensitivity of different lymphocyte populations to various brain tissue antigens.
    Brinkman CJ; Nillesen WM; Hommes OR; Lamers KJ; de Pauw BE; Delmotte P
    Ann Neurol; 1982 May; 11(5):450-5. PubMed ID: 6179459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.